Microbot Medical Inc. 8-K

What Happened
Microbot Medical Inc. announced in a Form 8-K (filed Feb 12, 2026) that its LIBERTY® Endovascular Robotic System was featured at the International Symposium on Endovascular Therapy (ISET), held February 9–12, 2026, in Miami Beach, Florida. The company issued a press release about the appearance, which is furnished as Exhibit 99.1 to the 8-K.

Key Details

• The 8-K was filed on February 12, 2026, under Item 7.01 (Regulation FD Disclosure).
• Event: ISET conference, February 9–12, 2026, in Miami Beach, Florida.
• Product: LIBERTY® Endovascular Robotic System was featured at the conference.
• The press release announcing the feature is included as Exhibit 99.1 to the filing.

Why It Matters
This disclosure signals Microbot seeking public visibility for its LIBERTY system at a major clinical conference, which can help raise awareness among clinicians and potential customers. The filing does not report sales, financial results, regulatory approvals, or other material corporate changes—only that the company publicly announced the product’s presence at ISET via a press release. Investors should view this as a marketing/awareness update rather than a financial or regulatory milestone.